Other
Kesimpta
Kesimpta is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
NCT04940065
recruiting
Kesimpta (Ofatumumab) Pregnancy Registry
NCT05634967
completed
A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis
NCT05334472
Clinical Trials (3)
Showing 3 of 3 trials
NCT04940065
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
NCT05634967
Kesimpta (Ofatumumab) Pregnancy Registry
NCT05334472
A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3